Live Analyst Rating Changes 1526 upgrades, downgrades & price-target moves · freshest Wall Street data, updated daily View live feed →
Analyst Tracker/Nate Crossett
EB
Nate Crossett
Wall Street Analyst
★★☆☆☆
#2138
on 13Foresight · ranked by our own returns
56%
Success Rate
+0.8%
Average Return
19 of 34 calls profitable · -30.8% vs benchmark
📈 Across the calls we could measure, roughly 56% of Nate Crossett's ratings turned a profit when each position was held for 2 year — averaging +0.8% per rating. These figures are computed by 13Foresight from historical prices, not supplied by the analyst.

Rating Distribution

3 Buy 2 Hold 1 Sell
Nate's Stock Coverage 36 ratings · 2026-06-21
Company Date Position Consensus Price Target 2-Yr Return
BXDC
Blackstone Digital Infrastructure Trust, Inc.
Jun 08, 2026 BUY Buy
+8.6% avg upside
11 analysts
$26.00
17.41% Upside
·
SILA
Sila Realty Trust, Inc.
Apr 21, 2026 HOLD Buy
-7.6% avg upside
5 analysts
$31.00
2.27% Upside
+0.5%
JAN
Janus Living, Inc. Class A
Apr 14, 2026 BUY Strong Buy
+10.3% avg upside
11 analysts
$27.00
2.89% Upside
·
EGP
Eastgroup Properties
Oct 27, 2025 BUY Strong Buy
-0.7% avg upside
31 analysts
$207.00
3.56% Upside
+12.3%
REXR
Rexford Industrial Realty
Oct 21, 2025 HOLD Buy
+31.1% avg upside
26 analysts
$47.00
41.83% Upside
-17.2%
ARE
Alexandria Equities
Oct 01, 2025 SELL Buy
+44.4% avg upside
26 analysts
+39.2%
LINE
Lineage, Inc.
Jun 12, 2025 SELL Hold
+11.5% avg upside
21 analysts
$42.00
1.44% Upside
+3.2%
COLD
Americold Realty
Jun 12, 2025 HOLD Buy
+30.5% avg upside
23 analysts
$18.00
28.01% Upside
-12.7%
WPC
W. P. Carey Inc.
Jun 09, 2025 HOLD Hold
+4.9% avg upside
18 analysts
$66.00
7.34% Downside
+19.0%
MPT
Medical Properties Trust
Mar 11, 2025 BUY Hold
+164.4% avg upside
24 analysts
$9.00
98.74% Upside
·
O
Realty Income
Feb 25, 2025 HOLD Buy
+10.4% avg upside
38 analysts
$61.00
1.33% Upside
+20.0%
NNN
NNN REIT
Nov 04, 2024 SELL Hold
+1.4% avg upside
29 analysts
$44.00
2.23% Downside
-13.2%
OHI
Omega Healthcare
Oct 31, 2024 BUY Buy
-3.6% avg upside
29 analysts
$49.00
9.94% Upside
+17.9%
DOC
Healthpeak Properties
Apr 26, 2024 BUY Strong Buy
+17.8% avg upside
42 analysts
$21.00
7.44% Upside
-0.0%
INVH
Invitation Homes
Jan 22, 2024 BUY Buy
+24.7% avg upside
34 analysts
$39.00
37.27% Upside
-15.1%
AMH
American Homes
Jan 22, 2024 BUY Strong Buy
+15.6% avg upside
31 analysts
$42.00
32.50% Upside
-7.2%
ADC
Agree Realty
Dec 13, 2023 HOLD Strong Buy
+8.4% avg upside
29 analysts
$64.00
12.71% Downside
+26.6%
NTST
NETSTREIT
Dec 13, 2023 HOLD Strong Buy
+9.5% avg upside
25 analysts
$17.00
11.43% Downside
+14.2%
VTR
Ventas
Oct 11, 2023 BUY Strong Buy
+0.3% avg upside
34 analysts
$47.00
42.42% Downside
+67.6%
DLR
Digital Realty
Jul 28, 2023 BUY Strong Buy
+0.9% avg upside
44 analysts
$138.00
26.71% Downside
+52.7%
PLD
Prologis
Jul 20, 2023 BUY Strong Buy
+2.9% avg upside
32 analysts
$141.00
0.28% Upside
-8.0%
EPRT
Essential Properties Realty
Jun 14, 2023 BUY Strong Buy
+16.7% avg upside
27 analysts
$29.00
1.21% Downside
+43.1%
VICI
VICI Properties
Jun 14, 2023 BUY Strong Buy
+31.9% avg upside
32 analysts
$41.00
56.07% Upside
+10.6%
GLPI
Gaming and Leisure
Jun 14, 2023 BUY Strong Buy
+19.2% avg upside
34 analysts
$63.00
41.19% Upside
+6.0%
GNL
Global Net Lease
Mar 16, 2023 SELL Buy
+11.8% avg upside
13 analysts
$13.00
41.06% Upside
+14.8%
EQIX
Equinix
Dec 14, 2022 BUY Strong Buy
-7.5% avg upside
49 analysts
$886.00
18.84% Downside
+42.8%
IRM
Iron Mountain
Dec 14, 2022 BUY Buy
-33.7% avg upside
19 analysts
$66.00
48.42% Downside
+117.2%
STAG
Stag Industrial
Sep 29, 2022 HOLD Buy
+0.5% avg upside
26 analysts
$35.00
7.43% Downside
+50.7%
GDS
GDS Holdings
May 23, 2022 BUY Strong Buy
+49.6% avg upside
18 analysts
$62.00
97.04% Upside
-73.2%
CHCT
Community Healthcare
May 06, 2022 BUY Buy
+97.7% avg upside
12 analysts
$51.00
192.60% Upside
-27.6%
FCPT
Four Corners Property
Apr 28, 2022 BUY Buy
+15.8% avg upside
16 analysts
$31.00
26.49% Upside
-9.6%
LAND
Gladstone Land
Feb 24, 2022 HOLD Buy
+102.7% avg upside
10 analysts
$29.00
234.93% Upside
-52.8%
OPEN
Opendoor Technologies
Jan 11, 2022 BUY Hold
-3.0% avg upside
29 analysts
$15.00
235.58% Upside
-70.1%
COMP
Compass
Jan 11, 2022 BUY Strong Buy
+11.8% avg upside
22 analysts
$11.00
9.91% Upside
-61.7%
OPAD
Offerpad Solutions
Jan 11, 2022 BUY Buy
+133.3% avg upside
13 analysts
$7.00
38.15% Upside
-88.1%
SAFE
Safehold
Nov 03, 2021 BUY Buy
+37.7% avg upside
15 analysts
$41.00
167.28% Upside
-85.5%
🔒 31 more ratings — with price targets, crowd consensus and our measured returns.
Free account unlocks every analyst's full coverage table.
Nate Crossett — Frequently Asked Questions
How accurate are Nate Crossett's stock ratings?
Based on the calls 13Foresight could measure, about 56% of Nate's ratings were profitable over a one-year hold, with an average return of -3.5% per rating, or -18.1% versus the S&P 500. We score every analyst the same way, from historical prices.
How is Nate ranked on 13Foresight?
Nate Crossett is currently ranked #2138 with a 2-star rating. Our rank blends hit rate, average return versus the market, and how many calls we have to judge — so a long, consistent record outweighs a few lucky picks. It is our own calculation, updated daily.
Which stocks does Nate cover?
Nate most recently has ratings on BXDC, SILA, JAN, EGP, REXR, ARE, LINE, COLD, WPC, MPT, O, NNN and 24 more. See the full coverage table above for positions, price targets and our measured returns.
Where can I see other analyst ratings?
Browse the full analyst leaderboard to compare Wall Street analysts ranked by their measured performance, success rate and average return.

Disclaimer: 13Foresight compiles analyst ratings and price targets from publicly available sources. Performance metrics, rankings and star ratings shown here are calculated independently by 13Foresight from historical market prices and may differ from figures published elsewhere. This information may be incomplete, delayed or inaccurate, is provided for research and informational purposes only, and is not investment advice. The underlying ratings and opinions are those of the respective analysts and their firms; 13Foresight accepts no liability for any decisions made based on this data.